产品名称：Human CD22 Antibody (Inotuzumab, Research Use)
产品编号：NBR-0012
针对靶点：CD22
抗体药商品名：Inotuzumab
抗体药描述：Inotuzumab ozogamicin, sold under the brand name Besponsa, is an antibody-drug conjugate medication used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: CD22
Synonyms: N/A
Target Description: Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45.
Ensembl: ENSG00000012124
Uniprot: P20273